Julia Villamayor - Publications

Real-World Insights into Stage I-III Non-Small Cell Lung Cancer in Spain in the Pre-Immunotherapy Era Using AI Techniques: The IntellyLUNG Study.

Journal: Life (Basel, Switzerland)

Published: May 18, 2026

Unveiling miR-451a and miR-142-3p as prognostic markers in non-small cell lung cancer via small extracellular vesicle liquid biopsy.

Journal: Clinical and translational medicine

Published: December 16, 2025

Novel therapies targeting delta-like ligand 3 (DLL3) in pulmonary and gastroenteropancreatic neuroendocrine carcinomas.

Journal: Cancer treatment reviews

Published: May 26, 2025

Efficacy of second and third lines of treatment in advanced soft tissue sarcomas: a real-world study.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: January 28, 2023

The BRCA Gene in Epithelial Ovarian Cancer.

Journal: Cancers

Published: January 15, 2022

Clinical and therapeutic management of a pleural fibrous tumor with ALK translocation.

Journal: Cirugia y cirujanos

Published: November 11, 2021

Understanding the immune response and the current landscape of immunotherapy in pancreatic cancer.

Journal: World journal of gastroenterology

Published: February 23, 2021

Prognostic factors in advanced pancreatic ductal adenocarcinoma patients-receiving second-line treatment: a single institution experience.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: February 01, 2021

Prognostic value of neutrophil-to-lymphocyte ratio in advanced cancer patients receiving immunotherapy.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: July 08, 2020

Incidence of venous thromboembolic events in cancer patients receiving immunotherapy: a single-institution experience.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: June 15, 2020

Prognostic value of neutrophil-to-lymphocyte ratio and other inflammatory markers in patients with high-risk soft tissue sarcomas.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: January 28, 2020